Cleared Traditional

K233561 - 3D Optical Coherence Tomography (3D OCT-1(type: Maestro2)) (FDA 510(k) Clearance)

Apr 2024
Decision
156d
Days
Class 2
Risk

K233561 is an FDA 510(k) clearance for the 3D Optical Coherence Tomography (3D OCT-1(type: Maestro2)). This device is classified as a Tomography, Optical Coherence (Class II - Special Controls, product code OBO).

Submitted by Topcon Corporation (Tokyo, JP). The FDA issued a Cleared decision on April 10, 2024, 156 days after receiving the submission on November 6, 2023.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.1570. Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases..

Submission Details

510(k) Number K233561 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 06, 2023
Decision Date April 10, 2024
Days to Decision 156 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code OBO - Tomography, Optical Coherence
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.1570
Definition Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases.